Aigen Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,503
Closed -$207K 851
2024
Q4
$207K Buy
+2,503
New +$197K 0.04% 601
2024
Q3
Sell
-7,003
Closed -$480K 832
2024
Q2
$480K Buy
+7,003
New +$418K 0.09% 319
2023
Q2
Sell
-14,641
Closed -$829K 837
2023
Q1
$829K Buy
+14,641
New +$939K 0.11% 213
2020
Q4
Sell
-6,595
Closed -$327K 874
2020
Q3
$327K Buy
+6,595
New +$340K 0.04% 506
2020
Q2
Sell
-9,409
Closed -$400K 985
2020
Q1
$400K Buy
+9,409
New +$465K 0.05% 506

Other funds holding GMED

Aigen Investment Management's GMED Position: Q1 2025 in Review

Aigen Investment Management sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 2,503 shares — an estimated $207K sold.

Aigen Investment Management first reported a position in GMED in Q1 2020 and held it in 5 quarters. The position peaked at $829K in Q1 2023. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Aigen Investment Management reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Aigen Investment Management sold 2,503 Globus Medical shares in Q1 2025, an estimated $207K.
  • Aigen Investment Management first reported a position in Globus Medical in Q1 2020 and held it in 5 quarters.
  • Aigen Investment Management's Globus Medical position peaked at $829K in Q1 2023.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Aigen Investment Management's 13F filing for Q1 2025, filed 12 May 2025.